Lipoproteins, HDL

"Lipoproteins, HDL" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases.

Descriptor ID	D008075
MeSH Number(s)	D10.532.432 D12.776.521.479
Concept/Terms	Lipoproteins, HDL Lipoproteins, HDL HDL Lipoproteins Heavy Lipoproteins Lipoproteins, Heavy High-Density Lipoproteins High Density Lipoproteins Lipoproteins, High-Density alpha-Lipoproteins alpha Lipoproteins alpha-1 Lipoprotein alpha-1 Lipoprotein

Below are MeSH descriptors whose meaning is more general than "Lipoproteins, HDL".

Chemicals and Drugs [D]
Lipids [D10]
Lipoproteins [D10.532]
Lipoproteins, HDL [D10.532.432]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Lipoproteins [D12.776.521]
Lipoproteins, HDL [D12.776.521.479]

Below are MeSH descriptors whose meaning is related to "Lipoproteins, HDL".

Below are MeSH descriptors whose meaning is more specific than "Lipoproteins, HDL".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lipoproteins, HDL" by people in this website by year, and whether "Lipoproteins, HDL" was a major or minor topic of these publications.

Bar chart showing 24 publications over 16 distinct years, with a maximum of 3 publications in 2010 and 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1998	0	1	1
1999	0	1	1
2003	1	0	1
2004	1	0	1
2005	2	0	2
2007	1	0	1
2008	0	1	1
2009	2	0	2
2010	2	1	3
2011	2	1	3
2013	1	0	1
2014	1	0	1
2015	1	1	2
2018	1	0	1
2020	1	1	2

Below are the most recent publications written about "Lipoproteins, HDL" by people in Profiles.

Roumeliotis A, Claessen B, Dangas G, Torguson R, Sartori S, Reisman A, Cao D, Chandiramani R, Nicolas J, Goel R, Chiarito M, Sharma M, Bandyopadhyay D, Baber U, Sweeny J, Barman N, Sharma S, Kini A, Mehran R. Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. Am J Cardiol. 2020 12 15; 137:1-6.

View in: PubMed
MacCuaig WM, McNally LR. Development of an 89Zr-labeled High-Density Lipoprotein Nanoparticle as a PET Agent to Track Efficacy of Immunotherapy. Radiol Imaging Cancer. 2020 05; 2(3):e204018.

View in: PubMed
Seckler HDS, Fornelli L, Mutharasan RK, Thaxton CS, Fellers R, Daviglus M, Sniderman A, Rader D, Kelleher NL, Lloyd-Jones DM, Compton PD, Wilkins JT. A Targeted, Differential Top-Down Proteomic Methodology for Comparison of ApoA-I Proteoforms in Individuals with High and Low HDL Efflux Capacity. J Proteome Res. 2018 06 01; 17(6):2156-2164.

View in: PubMed
Hsu CS, Liu TT, Wen SH, Wang CC, Yi CH, Chen JH, Lei WY, Orr WC, Fabio P, Chen CL. Clinical, metabolic, and psychological characteristics in patients with gastroesophageal reflux disease overlap with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2015 May; 27(5):516-22.

View in: PubMed
Marin MT, Dasari PS, Tryggestad JB, Aston CE, Teague AM, Short KR. Oxidized HDL and LDL in adolescents with type 2 diabetes compared to normal weight and obese peers. J Diabetes Complications. 2015 Jul; 29(5):679-85.

View in: PubMed
Rossi AP, Anderson KL, Brennan DC. JC polyoma virus and kidney disease. Kidney Int. 2014 May; 85(5):1242.

View in: PubMed
Freedman BI, Langefeld CD, Andringa KK, Croker JA, Williams AH, Garner NE, Birmingham DJ, Hebert LA, Hicks PJ, Segal MS, Edberg JC, Brown EE, Alarcón GS, Costenbader KH, Comeau ME, Criswell LA, Harley JB, James JA, Kamen DL, Lim SS, Merrill JT, Sivils KL, Niewold TB, Patel NM, Petri M, Ramsey-Goldman R, Reveille JD, Salmon JE, Tsao BP, Gibson KL, Byers JR, Vinnikova AK, Lea JP, Julian BA, Kimberly RP. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol. 2014 Feb; 66(2):390-6.

View in: PubMed
Nagao K, Hata M, Tanaka K, Takechi Y, Nguyen D, Dhanasekaran P, Lund-Katz S, Phillips MC, Saito H. The roles of C-terminal helices of human apolipoprotein A-I in formation of high-density lipoprotein particles. Biochim Biophys Acta. 2014 Jan; 1841(1):80-7.

View in: PubMed
Lin CP, Adrianto I, Lessard CJ, Kelly JA, Kaufman KM, Guthridge JM, Freedman BI, Anaya JM, Alarcón-Riquelme ME, Pons-Estel BA, Martin J, Glenn S, Adler A, Bae SC, Park SY, Bang SY, Song YW, Boackle SA, Brown EE, Edberg JC, Alarcón GS, Petri MA, Criswell LA, Ramsey-Goldman R, Reveille JD, Vila LM, Gilkeson GS, Kamen DL, Ziegler J, Jacob CO, Rasmussen A, James JA, Kimberly RP, Merrill JT, Niewold TB, Scofield RH, Stevens AM, Tsao BP, Vyse TJ, Langefeld CD, Moser KL, Harley JB, Gaffney PM, Montgomery CG. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun. 2012 Apr; 13(3):232-8.

View in: PubMed
Lyssenko NN, Hata M, Dhanasekaran P, Nickel M, Nguyen D, Chetty PS, Saito H, Lund-Katz S, Phillips MC. Influence of C-terminal a-helix hydrophobicity and aromatic amino acid content on apolipoprotein A-I functionality. Biochim Biophys Acta. 2012 Mar; 1821(3):456-63.

View in: PubMed

People

Explore

Similar Concepts

Top Journals